|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
Recommended reads: engineered niche, ALS, SCOTS trial, human genome "done"
|
|
|
|
David Weinberg over at Science-Based Medicine has his part two of a deep dive into the so-called SCOTS trial, which is a non-traditional pay-for-play study. I highly recommend it. SCOTS trial under the magnifying glass In this piece, Weinberg provides interesting background on the two people running SCOTS. I've had many concerns about the SCOTS "trial" over the years. See …
|
|
|
|
|
|
|
|
Hub of Regenerative Medicine & Stem Cell Meetings 2022
|
|
|
|
Science must go on and so must stem cell meetings in 2022 with all those great conferences out there, but hopefully this year will be better than 2020-2021. It seems that way with the pandemic easing in the U.S. and many other places. On the other hand, COVID is spiking in Asia and other regions. It's complicated. Every year I …
|
|
|
|
|
|
|
|
50 influencers on stem cells on Twitter to follow in 2022
|
|
|
|
When it comes to stem cells on Twitter and other social media, who do you follow now? Why them? Who are the top stem cell and regenerative medicine influencers to follow on Twitter and elsewhere in 2022? Stem cells on Twitter: great content amongst the noise Terrapin asked this kind of broad question to some within our community about 8 …
|
|
|
|
|
|
